158 related articles for article (PubMed ID: 167888)
21. Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets.
Hall DA; Hourani SM
Br J Pharmacol; 1993 Mar; 108(3):728-33. PubMed ID: 8467360
[TBL] [Abstract][Full Text] [Related]
22. Modification of platelet functions by monobromobimane, a fluorescent thiol group label.
Zucker MB; Mauss EA
Thromb Haemost; 1986 Apr; 55(2):228-34. PubMed ID: 3012818
[TBL] [Abstract][Full Text] [Related]
23. Effet of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3':5'-cyclic monophosphate.
Ball G; Brereton GG; Fulwood M; Ireland DM; Yates P
Biochem J; 1970 Dec; 120(4):709-18. PubMed ID: 4322038
[TBL] [Abstract][Full Text] [Related]
24. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
Michal F; Motamed M
Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
[TBL] [Abstract][Full Text] [Related]
25. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
26. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
Puri RN; Colman RF; Colman RW
Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907
[TBL] [Abstract][Full Text] [Related]
27. ADP induces partial platelet aggregation without shape change and potentiates collagen-induced aggregation in the absence of Galphaq.
Ohlmann P; Eckly A; Freund M; Cazenave JP; Offermanns S; Gachet C
Blood; 2000 Sep; 96(6):2134-9. PubMed ID: 10979958
[TBL] [Abstract][Full Text] [Related]
28. Human platelet secretion and aggregation induced by calcium ionophores. Inhibition by PGE1 and dibutyryl cyclic AMP.
Feinstein MB; Fraser C
J Gen Physiol; 1975 Nov; 66(5):561-81. PubMed ID: 172596
[TBL] [Abstract][Full Text] [Related]
29. Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation.
Lanza F; Cazenave JP; Beretz A; Sutter-Bay A; Kretz JG; Kieny R
Agents Actions; 1986 Aug; 18(5-6):586-95. PubMed ID: 3020942
[TBL] [Abstract][Full Text] [Related]
30. Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic acid.
Packham MA; Livne AA; Ruben DH; Rand ML
Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):849-56. PubMed ID: 8384448
[TBL] [Abstract][Full Text] [Related]
31. Collagen-induced platelet aggregation: the role of adenine nucleotides and the release reaction.
Kattlove H; Gomez MH
Thromb Diath Haemorrh; 1975 Dec; 34(3):795-805. PubMed ID: 813326
[TBL] [Abstract][Full Text] [Related]
32. Potentiation by adrenaline of agonist-induced responses in normal human platelets in vitro.
Haaland HD; Holmsen H
Platelets; 2011; 22(5):328-37. PubMed ID: 21388249
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of agonist-induced platelet aggregation, Ca2+ mobilization and granule secretion by guanosine 5'-[beta-thio]diphosphate and GDP in intact platelets. Evidence for an inhibitory mechanism unrelated to the inhibition of G-protein-GTP interaction.
Krishnamurthi S; Patel Y; Kakkar VV
Biochem J; 1988 Feb; 250(1):209-14. PubMed ID: 3355512
[TBL] [Abstract][Full Text] [Related]
34. Interaction of prostaglandins E1 and E2 in regulation of cyclic-AMP and aggregation in human platelets: evidence for a common prostaglandin receptor.
McDonald JW; Stuart RK
J Lab Clin Med; 1974 Jul; 84(1):111-21. PubMed ID: 4365532
[TBL] [Abstract][Full Text] [Related]
35. Platelet aggregation. I. Regulation by cyclic AMP and prostaglandin E1.
Marquis NR; Vigdahl RL; Tavormina PA
Biochem Biophys Res Commun; 1969 Sep; 36(6):965-72. PubMed ID: 4310150
[TBL] [Abstract][Full Text] [Related]
36. Role of extracellular ATP metabolism in regulation of platelet reactivity.
Birk AV; Broekman MJ; Gladek EM; Robertson HD; Drosopoulos JH; Marcus AJ; Szeto HH
J Lab Clin Med; 2002 Sep; 140(3):166-75. PubMed ID: 12271274
[TBL] [Abstract][Full Text] [Related]
37. Extracellular ATP inhibits agonist-induced mobilization of internal calcium in human platelets.
Soslau G; McKenzie RJ; Brodsky I; Devlin TM
Biochim Biophys Acta; 1995 Jul; 1268(1):73-80. PubMed ID: 7626665
[TBL] [Abstract][Full Text] [Related]
38. Adenine nucleotide metabolism of blood platelets. X. Formaldehyde stops centrifugation-induced secretion after A23187-stimulation and causes breakdown of metabolic ATP.
Holmsen H; Setkowsky Dangelmaier CA
Biochim Biophys Acta; 1977 Mar; 497(1):46-61. PubMed ID: 321037
[TBL] [Abstract][Full Text] [Related]
39. P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets.
Fälker K; Lange D; Presek P
Thromb Haemost; 2005 May; 93(5):880-8. PubMed ID: 15886804
[TBL] [Abstract][Full Text] [Related]
40. Effect of epinephrine on fibrinogen receptor exposure by aspirin-treated platelets and platelets from concentrates in response to ADP and thrombin.
Peerschke EI
Am J Hematol; 1984 May; 16(4):335-45. PubMed ID: 6326566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]